Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #259670 on Elite Pharmaceuticals Inc (ELTP)
Couch
06/03/17 10:17 AM
#259671 RE: jour_trader #259670
Was that labeling issue in the notes of meeting with the FDA or a misunderstanding by management? Many factors at play here. We are now on our 3rd FDA Director dealing with SequestOx. Each has a different view of the science, data & risks. Science is sometimes more gray than black & white and this is no different. I am sure Gottlieb will want to make his mark on this one too, protecting BP, of course.